# Efficacy and safety of anti-amyloid-β monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis

Review · Danko Jeremic, Juan D. Navarro‐López, Lydia Jiménez‐Díaz

- Archive id: doi:10.1016/j.arr.2023.102012
- Published: 2023-07-07
- Venue: Ageing Research Reviews
- DOI: https://doi.org/10.1016/j.arr.2023.102012
- PMID: 37423541
- Citations: 77
- Source URL: https://doi.org/10.1016/j.arr.2023.102012
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.